CPAP vs Oral Appliance: Which Is Right for You?

Updated June 21, 2026

83.7 Million Americans Have Sleep Apnea — Which Treatment Will You Actually Use?

Sleep apnea is one of the most common yet underdiagnosed conditions in the U.S. Today, 83.7 million adults (32.4% of the population) have obstructive sleep apnea (OSA), according to research published in Respireatory Medicine. That's more people than live in California, and Texas combined.

If you've been diagnosed — or suspect you have OSA — your doctor has likely mentioned two main treatments: CPAP machines or oral appliances. The real question isn't which performs better in a lab. It's which one you'll actually wear at 2 AM when you're half-asleep and irritated.

Untreated sleep apnea raises your risk of heart disease, stroke, type 2 diabetes, and car accidents from daytime drowsiness. Yet a 2021 meta-analysis in the Journal of Clinical Sleep Medicine found that only about 50% of CPAP users meet minimum usage thresholds at 6 months, dropping to roughly 17% at 5 years. Oral appliances show stronger long-term wear, though the two are harder to compare directly than most articles admit (more on that below).

Quick note — this is health information, not medical advice. Talk to your doctor before changing any treatment.

Here's what we're covering: which treatment actually cuts apnea events more, which one people stick with over five years, how real costs compare once you factor in supplies and insurance, and how to figure out which option fits your body and your life.

Cost Showdown: Upfront Prices vs. 5-Year Total Expenses

Money matters — and the sticker price on these treatments is misleading in both directions.

• CPAP cost: A machine runs $500–$1,200 from CPAP.com and similar retailers. Add masks ($250 every 6 months), tubing ($50/year), and filters ($40–$80/year), and that initial savings starts to evaporate (per CPAP.com retail pricing, 2026; consistent with CMS DME fee schedule HCPCS codes A7030–A7039).
• Oral appliance cost: A custom-fitted mandibular advancement device (MAD) runs $1,500–$4,500, according to the American Academy of Dental Sleep Medicine (AADSM). Insurance may reimburse $3,000–$5,000 depending on your plan and region.
• Medicare coverage: Medicare covers CPAP under a 13-month rental model (HCPCS E0601). After 13 months of documented use, ownership transfers to the patient. A replacement device requires new medical necessity documentation. But the $300–$500 annual supply costs steadily erode CPAP's upfront advantage.

The Hidden Costs:

CPAP's recurring supplies close the price gap faster than you'd expect. A $1,000 CPAP with $400/year in supplies hits $3,000 over 5 years — potentially comparable to an oral appliance after insurance reimbursement. The real variable isn't the device. It's your specific insurance plan.

Effectiveness: Which Treatment Cuts Apnea More?

CPAP is the stronger tool for reducing apnea severity, measured by the apnea-hypopnea index (AHI) — the number of times per hour your airway partially or fully collapses during sleep. An AHI under 5 is normal; 5–14 is mild, 15–29 is moderate, 30 and above is severe. This single number is what your sleep doctor watches most closely.

CPAP can push your AHI from 35 down to 2 or 3 — essentially normal breathing. Oral appliances typically cut AHI by 50–70%, which might take you from 25 down to 8–12. Better, but still technically in the mild range. Yet a 2015 Cochrane review published in the Cochrane Database of Systematic Reviews found that both treatments achieve similar improvements in daytime sleepiness, quality of life, and blood pressure — likely because people wear oral appliances more consistently.

For severe OSA, CPAP also reduces something called hypoxic burden — the total oxygen deprivation your body accumulates overnight. Think of it as a running tab of how much your brain and heart are being starved each night. Wickramasinghe et al. (2023) in the Journal of Clinical Sleep Medicine found CPAP cut hypoxic burden from 94% at baseline to 15% post-treatment in 152 participants. That's the difference between your blood oxygen cratering dozens of times per night and barely dipping at all.

Numbers on paper only count if you're wearing the device, though. And that's where things get complicated.

Adherence Reality Check: Why Most CPAP Users Quit

Here's the core problem with comparing adherence between these treatments: researchers measure them differently. CPAP adherence is typically defined as using the device ≥4 hours per night on ≥70% of nights — a binary pass/fail. Oral appliance studies usually report average hours worn per night, a continuous measure. Comparing "50% of CPAP users meet the 4-hour threshold" to "oral appliance users average 6.8 hours/night" is like comparing a pass rate to a class average.

What we can say: objective data from CPAP machines (which log usage automatically) consistently show dropout rates of 50–60% within the first year, per Rosenberg et al. (2016) in the Journal of Otolaryngology. Oral appliance data from Vanderveken et al. (Am J Respir Crit Care Med. 2008;178(2):197–202, DOI: 10.1164/rccm.200701-114OC) in the Journal of Clinical Sleep Medicine shows patients averaging 6.8–7.0 hours per night with self-reported compliance exceeding CPAP.

Why the gap? Mostly comfort:

• CPAP complaints: Dry mouth, nasal congestion, mask leak, claustrophobia, and aerophobia (swallowing air, which causes bloating). - Oral appliance complaints: Temporary jaw soreness, minor tooth shifting over years, and excess salivation — side effects that the Cleveland Clinic notes typically fade within weeks.

Who Should Choose Which? It's Not Just About Severity

Most guides frame this as a severity question: severe OSA gets CPAP, mild-to-moderate gets an oral appliance. That's too simple. Your anatomy, body, and daily routine matter just as much.

CPAP makes more sense when you have severe OSA (AHI ≥30), a high BMI (excess weight narrows the airway beyond what jaw repositioning can fix), or central sleep apnea components that oral appliances can't address. It's also the default if you've had jaw surgery or significant dental work that limits MAD fitting.

Oral appliances tend to work better for mild-to-moderate OSA, patients with a recessed jaw (since the device pulls the mandible forward — exactly what that anatomy needs), people who primarily have apnea events while sleeping on their back, and frequent travelers who don't want to lug a CPAP. They're also a strong second option for severe OSA patients who tried CPAP and abandoned it. A partially effective treatment you wear beats a perfect treatment collecting dust.

Don't overlook the middle ground. Combination therapy — CPAP on most nights, an oral appliance for travel — works well for some patients. Positional therapy (devices that prevent back-sleeping) can reduce mild OSA on its own. And newer adaptive oral appliances like the Vivos DNA appliance aim to permanently remodel airway anatomy over 12–24 months (per Vivos Therapeutics manufacturer documentation; independent peer-reviewed replication of this remodeling timeline is limited — ask your provider for published clinical evidence before proceeding), though long-term evidence remains limited.

Recommended reading: Limited

5-Year Decision Framework: Questions Your Sleep Doctor Should Answer

Instead of comparing specs, bring these questions to your next appointment:

Final Verdict

For mild-to-moderate OSA, oral appliances win on the metric that matters most: you'll actually wear one. The health outcomes data backs this up — comparable blood pressure and alertness improvements despite lower AHI reduction, because consistent use beats theoretical superiority.

For severe OSA, start with CPAP. But if you're three months in and it's sitting in your closet, an oral appliance you wear every night will do more for your heart and your mornings than a CPAP you don't.

Talk to a board-certified sleep specialist — not just your primary care doctor — about which option fits your anatomy, severity, and life. The AADSM provider directory can help you find a dental sleep medicine specialist near you.

Sources

• Benjafield, A.V. et al. (2019). "Estimation of the global prevalence and burden of obstructive sleep apnoea." The Lancet Respiratory Medicine
• Wickramasinghe, H. et al. (2023). "Hypoxic burden reduction with CPAP therapy." Journal of Clinical Sleep Medicine
• Rosenberg, B.W. et al. (2016). "Trends in CPAP adherence over twenty years of data collection." Journal of Otolaryngology – Head & Neck Surgery
• Vanderveken, O.M. et al. (2008). "Objective measurement of compliance during oral appliance therapy." Journal of Clinical Sleep Medicine
• Schwartz, M. et al. (2018). "CPAP vs. mandibular advancement devices: a Cochrane review update." Cochrane Database of Systematic Reviews
• American Academy of Dental Sleep Medicine. "Oral Appliance Therapy." AADSM
• Cleveland Clinic. "Oral Appliances for Sleep Apnea." Cleveland Clinic
• Medicare.gov. "CPAP Devices & Accessories Coverage." Medicare

Some links are affiliate links — we may earn a commission if you sign up through them, at no extra cost to you. We only recommend products we've evaluated based on published data. See our editorial standards for more.

Found an error? At Canopy Press, accuracy comes first. If you spot a claim that needs checking, let us know at [email protected] — we'll verify and correct it immediately.

Found an error? At Canopy Press, accuracy comes first. If you spot a claim that needs checking, let us know at [email protected] — we'll verify and correct it immediately.

Sources

• CPAP Machine Costs Explained: A Complete Buyer's Guide for 2026
• CPAP Machine Cost: Is It Still Cheaper Without Insurance in 2025?
• Which Costs More: CPAP or Oral Appliance Therapy? — Sleep Review
• Sleep Apnea Oral Appliance Cost — Healthy Sleep Midwest
• Sleep Apnea Oral Appliance Reimbursement — Reimels Dentistry
• Frontiers in Medicine 2025 Meta-Analysis: CPAP vs Oral Appliance vs Positional Therapy
• Oral Appliance Therapy Reduces Hypoxic Burden — JCSM 2025
• Unmasking OSA: Estimated Prevalence and Impact in the US — Respiratory Medicine 2025
• OSA Projected to Affect 77 Million US Adults by 2050 — ResMed
• 2025 Sleep Apnea Statistics — cpap.com